FIELD: medicine.
SUBSTANCE: invention refers to experimental medicine, pathophysiology and pharmacology and can be used for studying mechanisms of formation, progression and therapy of combined cardiac and renal involvement in preclinical studies. Disclosed is a method for creating an experimental model of a toxic multiple organ pathology in the form of combined heart and kidney involvement in experimental animals. Cardiotoxicity is manifested by development of syndrome of elongated QT interval without morphological signs of heart tissue changes. Renal involvement was characterized by functional (reduced creatinine clearance, hyperuricemia) and coarse morphological changes of the tubular epithelium. Modeling of the toxic combined pathology of the heart and kidneys is based on a complex effect of a number of anti-tuberculosis preparations with cardiotoxic potential of a different mechanism of action and a combination with a direct nephrotoxic drug preparation, and factors (sex, age of animals) initiating a cascade of functional disorders leading to the syndrome of an elongated QT interval on a background of organic renal involvement.
EFFECT: method provides absence of lethal outcome of experimental animals and short period of pathological condition development.
5 cl, 2 dwg, 6 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR SIMULATING TOXIC HEART INVOLVEMENT IN RATS | 2019 |
|
RU2726926C1 |
METHOD FOR MODELING ACQUIRED LONG QT INTERVAL SYNDROME USING COMPLEX OF ANTI-TUBERCULOSIS AND ANTIMICROBIAL DRUGS | 2022 |
|
RU2794488C1 |
METHOD FOR MODELING DRUG NEUROTOXICITY USING COMPLEX OF ANTI-TUBERCULOSIS AND ANTIMICROBIAL DRUGS | 2022 |
|
RU2795524C1 |
METHOD FOR REDUCING NEUROTOXICITY CAUSED BY A COMPLEX OF ANTI-TUBERCULOSIS DRUGS IN EXPERIMENT | 2023 |
|
RU2820957C1 |
METHOD OF DIFFERENTIAL DIAGNOSIS OF ARRHYTHMIAS IN ADOLESCENTS WITH RESPIRATORY TUBERCULOSIS | 2023 |
|
RU2814004C1 |
METHOD FOR SELECTING SHORTENED CHEMOTHERAPY REGIMENS FOR THE TREATMENT OF PULMONARY TUBERCULOSIS | 2022 |
|
RU2805496C1 |
METHOD FOR FORMATION OF SHORTENED REGIMENS OF CHEMOTHERAPY FOR RESPIRATORY TUBERCULOSIS WITH MULTIPLE AND EXTENSIVE DRUG RESISTANCE OF MBT IN OLDER CHILDREN AND ADOLESCENTS | 2020 |
|
RU2748957C1 |
USE OF NANOPHOSPHOLIPID COMPOSITION OF RIFAMPICINE TOGETHER WITH PROTIONAMIDE OR ITS NANOPHOSPHOLIPID FORM IN TREATMENT OF TUBERCULOSIS | 2014 |
|
RU2595881C2 |
METHOD OF TREATING BRONCHIAL TUBERCULOSIS IN PATIENTS WITH LUNG TUBERCULOSIS WITH A MULTIDRUG RESISTANCE / EXTENSIVELY DRUG RESISTANCE OF DISEASE CAUSATIVE AGENT | 2019 |
|
RU2727760C1 |
STRAIN MYCOBACTERIUM TUBERCULOSIS 326/18/47 B-9673 FOR EVALUATION OF THE EFFECTIVENESS OF ANTI-TB DRUGS AND DISINFECTANTS | 2022 |
|
RU2785409C1 |
Authors
Dates
2020-07-16—Published
2019-12-18—Filed